QbD Guided Development and Validation of RP-HPLC Method for Quantitative Estimation of Ilaprazole
Authors/Creators
Description
The quality by design proved that new simple, sensitive, appropriate, accurate, and strong
reversed-phase (RP-HPLC) method was developed and validated to determine ilaprazole in
its bulk and tablet dosage form. With Central Composite Design, the chromatographic
condition was optimized. Separating was performed on Chromeleon 7.3 on Agilent Zorbax
C18 column (250 mm x 4.6mm; 5micrometer) of an HPLC system. The identifying was done
at 276 nm.
The developed RP-HPLC method used the following methods: used mobile phase Phosphate
buffer: Acetonitrile in the ratio of 60:40 v/v and flow rate 1.0 mL/min and retention time was
found to be 5.2 min. The results analysis method was verified in terms of linearity, accuracy,
precision, specificity, robustness. The correlation coefficient (r2) of the developed method
was 0.9988 and thus justified the linearity of the developed method. The accuracy of the
method RSD were less than 2.0. The percentage of recoveries of ilaprazole were found to be
100.88. The proposed strategy was foreseeable and firm. The proposed method was good in
predictability and robustness.